Viewing StudyNCT00553618



Ignite Creation Date: 2024-05-05 @ 6:51 PM
Last Modification Date: 2024-10-26 @ 9:37 AM
Study NCT ID: NCT00553618
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2021-10-29
First Post: 2007-11-01

Brief Title: Adjuvant Combined Interleukin 2 Proleukin and DTIC Dacarbazine in High-risk Melanoma Patients
Sponsor: University of Louisville
Organization: University of Louisville

Conditions & Keywords Data

Conditions:
Name
Metastatic Melanoma
Keywords:
Name View
adjuvant View
Interleukin 2 View
Proleukin View
DTIC View
Dacarbazine View
metastatic melanoma View